Harvard Pulmonary And Critical Care Medicine 2026

Harvard Pulmonary And Critical Care Medicine 2026

179.97 USD In stock Buy at Merchant

About Harvard Pulmonary And Critical Care 2026 Harvard Pulmonary And Critical Care 2026 offers a comprehensive update on state-of-the-art evaluation, diagnosis, treatment, and procedures for patients with common, rare, and challenging pulmonary conditions and patients requiring critical care. Originally delivered as a live online course with live streaming and electronic Q&A. This Harvard Pulmonary And Critical Care 2026 program covers everything from sepsis guidelines and ARDS management to interventional pulmonology, biologics in asthma, pulmonary hypertension, and point-of-care ultrasound in the ICU. All sessions are led by master clinicians who deliver information in inspiring and entertaining ways and provide specific recommendations to incorporate the latest updates into your practice. New in 2026: breaking news updates, current sepsis guidelines, high-flow oxygen therapy, biologics in lung disease, new vasopressor concepts in septic shock, new drugs in pulmonary hypertension, evidence on sedation and early mobility, POCUS in ICU, lung microbiome implications, targeted temperature management updates, steroid-sparing agents for ILD, latest PE strategies, end-of-life discussions guidance, and new CF treatments. Why Choose Harvard Pulmonary And Critical Care 2026 ✓ Harvard faculty — recognized leaders in pulmonary and critical care medicine ✓ 63 + 5 bonus video lectures with full VTT subtitles for accessibility ✓ 54 PDF handouts with charts, algorithms, and reference tables ✓ 10 expanded Q&A sessions with real-world case discussions ✓ Lifetime offline access on all devices — perfect for ICU on-call reference ✓ One of the most current curricula in pulmonary, critical care, and sleep medicine Conditions Covered Pulmonary: IPF • Non-IPF ILD • Sarcoidosis • Bronchiectasis • Cystic Fibrosis • Lung Nodules • Lung Cancer • COPD • Asthma • Hypersensitivity Pneumonitis • Pleural Disease • Pneumonia • Tuberculosis • Atypical Mycobacterial Disease • Pulmonary Hypertension • Thromboembolism • Aspergillus Lung Disease • Lung Transplantation Critical Care: ARDS • Sepsis • Vasopressors • Ventilator Management • Renal Replacement Therapy • Neurologic Issues in ICU • Post-Cardiac Arrest Care • Surgical Emergencies • Acute Pancreatitis • Hemorrhage Management • Post-ICU Care Syndrome Sleep: Sleep-Disordered Breathing • Obstructive Sleep Apnea • Central Sleep Apnea • Sleep Diagnostics • Noninvasive Ventilation Learning Objectives 🎯 Upon Completion You Will Be Able To ✓ Evaluate the pathophysiology of lung disease and critical illness, including key pathologic and radiologic features ✓ Apply evidence from recent literature to clinical case management ✓ Apply new clinical practice guidelines to improve patient outcomes ✓ Utilize diagnostic and therapeutic tools offered by specialists outside pulmonary/critical care to optimally care for complex patients ✓ Review the latest evidence and best clinical practices for fluid resuscitation and vasopressor use Complete Curriculum — 63 Sessions 🫁 Section 1 — Pulmonary Diseases & Lung Transplant 01. Breaking News in Pulmonary Medicine — Dr. Benjamin Medof 02. Cystic Fibrosis — Understanding CFTR and New Treatment — Dr. Isabel Neuringer 03. Beyond Cystic Fibrosis — Diagnosis and Management of Non-CF Bronchiectasis — Dr. Christopher Richards 04. Lung Transplantation 2026 — Referral, Patient Selection, Allocation, and COVID — Dr. Brian Keller 05. Exercise and Cardiopulmonary Disorders — Indications and Interpretation — Dr. C. Corey Hardin 🔬 Section 2 — Interstitial Lung Disease & Pathology 07. Pulmonary Pathology — Interstitial Lung Disease — Dr. Lida Hariri 08. Looking Deeper — Patterns and Insights from Chest Radiology — Dr. Amita Sharma 09. Evolving Concepts in Diagnosis and Management of CTD-Associated ILD — Dr. Barry Shea 10. Hypersensitivity Pneumonitis — Pigeons, Farmers, and Hot Tubs, Oh My! — Dr. Sydney Montesi 11. Treatment Challenges of Pulmonary Sarcoidosis — Dr. Robert Hallowell 12. Diagnosis and Management of IPF — When, Why, and How to Use the Newest Drugs — Dr. Grace Peloquin 💨 Section 3 — Critical Care: Ventilation & ARDS 14. Sedation, Analgesia, and Early Mobility — The State of the Art in 2026 — Dr. Crystal North 15. Noninvasive Respiratory Support for Acute Respiratory Failure — Less May NOT Be Best — Carolyn La Vita, MHA, RRT 16. Novel Ventilator Modes — The Hype and Reality — Carolyn La Vita, MHA, RRT 17. ARDS — State-of-the-Art Strategies to Protect the Lung — Dr. Jehan Alladina 18. After the ICU — Post-ICU Care Syndrome and Recovery — Dr. George Alba 💧 Section 4 — Sepsis, Fluids & Hemodynamics 20. From Ancient Egypt to Balanced Crystalloids — Medicine’s Attempts to Manage Sepsis — Dr. Eric Schmidt 21. Fluid Responsiveness — Dr. David Ziehr 22. Vasopressors in Septic Shock — Old Friends and New — Dr. Jason Griffith 23. Approach to Empiric Antibiotics in the ICU — Dr. Alyssa Letourneau 24. Approach to the Immunocompromised Critically Ill Patient — Dr. Lisa Bebell 25. Renal Replacement Therapy in the ICU — What and When to Start (or Not) — Dr. Andrew Allegretti 🧠 Section 5 — Neurologic & Surgical ICU Emergencies 27. Common Neurologic Issues in the ICU — Dr. Sahar Zafar 28. TTM and Neuro-prognostication After Cardiac Arrest — Dr. David Greer 29. Surgical Emergencies in the Medical ICU — Dr. Noelle Saillant 30. Updates in Management of Acute Pancreatitis — Dr. Casey Luckhurst 31. Advanced Cardiac Support in the ICU — Dr. David Dudzinski 🔊 Section 6 — POCUS, Pneumonia & End-of-Life 33. Breaking Updates in Critical Care — Dr. Kathryn Hibbert 34. Management of the Acutely Hemorrhaging Patient — Dr. Raghu Chivkula 35. Point-of-Care Ultrasound in the Intensive Care Unit — Dr. Jonah Rubin 36. Pneumonia (Community and Hospital Acquired) — Using the Newest Guidelines — Dr. Joshua Metlay 37. Prognosis and Uncertainty in the ICU — Dr. Emily Rubin 38. Palliative Care in Advanced Lung Disease — Dr. Jaclyn Shameklis 🔧 Section 7 — Interventional Pulmonology & Lung Cancer 40. Pleural Disease — 2026 Updates — Dr. Fayez Kheir 41. Interventional Pulmonology in 2026 — Dr. Colleen Keyes 42. Interventional Bronchoscopy in COPD — Valves, Coils, and Beyond — Dr. Colleen Keyes 43. Treatment of NSCLC — Traditional Chemo, Targeted Therapy, and Immunotherapies — Dr. Allison Chang 44. COPD 2026 — Dr. Walter O’Donnell 🦠 Section 8 — Infections, Asthma & Nodules 46. Aspergillus Lung Disease — Dr. Rod Rahimi 47. Asthma — What’s New in 2026 — Dr. Miranda Theodore 48. New Therapeutics in Lung Disease — The Age of Immunotherapy — Dr. Benjamin Medof 49. A Strategic Approach to the Management of Pulmonary Nodules — Dr. Angela Frank 50. Tuberculosis in 2026 — Dr. Jodian Pinkney 51. Nontuberculous Mycobacterial Disease — Navigating the Labyrinth — Dr. Rocio Hurtado 🩸 Section 9 — Pulmonary Embolism & Pulmonary Hypertension 53. Thrombotic Mechanisms and Antithrombotic Agents — How Do the New Oral Agents Fit in 2026 — Dr. Rachel Rosovsky 54. Pulmonary Embolism — An Update — Dr. Alison Witkin 55. Pulmonary Hypertension — Categorization and Evaluation — Dr. Josanna Rodriguez-Lopez 56. Pulmonary Hypertension Management — Dr. Alexandra Wong 57. Vasculitis and ANCA — Dr. Rachel Knipe 😴 Section 10 — Sleep Medicine 59. Obstructive Sleep Apnea — Dr. James Mojica 60. Central Sleep Apnea 2026 — Dr. James Mojica 61. Sleep Diagnostics — Dr. Katherine Dudley 62. Noninvasive Ventilation — Dr. Katherine Dudley Plus: 10 expanded Q&A sessions (06, 13, 19, 26, 32, 39, 45, 52, 58, 63) interspersed throughout, featuring discussion of complex real-world cases with the faculty. Who Should Take Harvard Pulmonary And Critical Care 2026 This Harvard Pulmonary And Critical Care 2026 program is best for Physicians, Nurse Practitioners, and Physician Assistants in: ✓ Pulmonology ✓ Critical Care ✓ Internal Medicine ✓ Hospital Medicine ✓ Sleep Medicine … and any clinician seeking comprehensive annual updates across respiratory diseases, ICU management, and sleep medicine.

AI Readiness

Good foundation, but some important product data is still missing.

72%